US Broker Ratings

Celcuity Inc. (CELC) Stock Analysis: Exploring a 5.96% Potential Upside in the Biotechnology Sector

Celcuity Inc. (NASDAQ: CELC), a prominent player in the biotechnology sector, is drawing investor attention with its promising drug development initiatives and a notable potential upside of 5.96%, as indicated..

Butterfly Network, Inc. (BFLY): Investor Outlook on a 56.73% Potential Upside

Butterfly Network, Inc. (BFLY), a pioneer in the healthcare sector, is making waves with its innovative medical devices, particularly in the ultrasound imaging domain. Known for its cutting-edge Butterfly iQ+..

CeriBell, Inc. (CBLL) Stock Analysis: 45.52% Potential Upside with Strong Buy Ratings in Medical Devices Sector

CeriBell, Inc. (CBLL), a U.S.-based medical technology company, is making waves in the healthcare sector with its innovative solutions for the diagnosis and management of serious neurological conditions. Focused primarily..

AtaiBeckley Inc. (ATAI): Biotech Stock with a Staggering 265% Potential Upside and Strong Buy Ratings

AtaiBeckley Inc. (ATAI), a dynamic player in the biotechnology sector, is capturing investor attention with its substantial growth potential and an impressive 265.24% potential upside, according to analyst ratings. As..

STAAR Surgical Company (STAA) Stock Analysis: Exploring the 38.40% Potential Upside

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, has been generating buzz among healthcare investors for its innovative ocular products. Known for its..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 247% Potential Upside in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands out in the biotechnology sector with its innovative approach to developing GPCR-targeted biologic medicines. Despite a current price of $22.86 and a recent slight..

SIGA Technologies Inc. (SIGA) Stock Analysis: Exploring the Healthcare Innovator’s 39.94% ROE and Strategic Positioning

SIGA Technologies Inc. (NASDAQ: SIGA), a prominent player in the healthcare sector, stands out as a commercial-stage pharmaceutical company with a focus on the health security market. Headquartered in New..

Bioventus Inc. (BVS) Stock Analysis: An 82.70% Potential Upside Attracts Bullish Investor Sentiment

Bioventus Inc. (BVS), a key player in the healthcare sector focusing on medical devices, is capturing attention with an exceptional potential upside of 82.70%. This Durham, North Carolina-based company, founded..

Personalis, Inc. (PSNL) Stock Analysis: A 50% Upside Potential Amidst Strategic Innovations

For investors with a keen eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) presents an intriguing opportunity. Specializing in advanced cancer genomic tests and services, the company is at..

REGENXBIO Inc. (RGNX) Investor Outlook: Exploring a 202% Potential Upside with Promising Gene Therapy Innovations

REGENXBIO Inc. (NASDAQ: RGNX) is a prominent player in the biotechnology sector, with a focus on developing innovative gene therapy solutions through its proprietary NAV Technology Platform. With a market..

Septerna, Inc. (SEPN) Stock Analysis: Biotechnology Innovator with a 38.53% Potential Upside

In the dynamic world of biotechnology, Septerna, Inc. (NASDAQ: SEPN) emerges as a compelling player with a focus on developing innovative treatments for a spectrum of diseases. Based in South..

Pharvaris N.V. (PHVS) Stock Analysis: A Promising 85% Potential Upside for Biotech Investors

Pharvaris N.V. (NASDAQ: PHVS), a Switzerland-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to treating rare diseases, particularly angioedema. With a market capitalization of..

EyePoint, Inc. (EYPT) Stock Analysis: A Potential 183% Upside in Biotech Breakthrough

Investors with an eye on the biotechnology sector might find EyePoint, Inc. (NASDAQ: EYPT) a compelling opportunity, especially given its potential upside of 183.45%. EyePoint is carving a niche in..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Through Challenges with a 13.62% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a significant player in the healthcare sector specializing in medical care facilities, is currently trading at $8.74, which reflects a slight decline of 0.02%...

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a 19.10% Potential Upside in the Healthcare Sector

Investors looking to explore opportunities within the biotechnology sector may find Fortrea Holdings Inc. (FTRE) intriguing, especially given its potential for a 19.10% upside based on current analyst ratings. As..

Valneva SE (VALN) Stock Analysis: A 36.25% Potential Upside in the Vaccine Market

Investors with an interest in the biotechnology sector might find Valneva SE (NASDAQ: VALN) an intriguing opportunity. This French-based specialty vaccine company, with a market cap of $808.98 million, is..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Biotechnology Gem with 271% Potential Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a prominent player in the biotechnology sector, is catching the attention of investors with its remarkable potential for substantial returns. The company, specializing in genetic..

InnovAge Holding Corp. (INNV) Stock Analysis: What a 33% Downside Means for Investors

InnovAge Holding Corp. (NASDAQ: INNV) is at the forefront of providing comprehensive medical and ancillary services tailored for seniors who wish to live independently. Operating through the Program of All-Inclusive..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Cannabis Sector with a 6.10% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, continues to capture investor attention with its strategic operations..

AbCellera Biologics Inc. (ABCL): Investor Outlook Highlights a 253.72% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a pioneering player in the biotechnology sector, has become a focal point for investors looking to capitalize on its significant growth potential. Headquartered in Vancouver,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds